Corporate Information

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition.

Now public on the TSX

Symbol CBD.U

Please complete the form below to receive the Company’s Investor Presentation and Prospectus. If you have any questions, please call us at 416-803-5638 or email us at [email protected].

HempFusions Family Of Brands

HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations.

Built on a foundation of regulatory compliance and human safety, HempFusion's diverse product portfolio comprises 46 SKUs including tinctures, proprietary FDA Drug Listed Over The Counter (OTC) Topicals, Doctor/Practitioner Lines and more.

Our Strong Focus on Research And Development

With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable and HempFusion's wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States according to SPINs reported data. HempFusion's CBD products are based on a proprietary Whole Food Hemp Complex™️ and are available in-store or by visiting HempFusion online at www.hempfusion.com or www.probulin.com.

Investment Highlights

  • Compliance Driven

    • HempFusion’s uncompromising approach to regulatory compliance has positioned the Company for potential entry into major retail markets that may be unavailable to other CBD companies, this includes: Large food, drug and mass retail chains (“Food/Drug/Mass” or “Big Box”), Doctor/Practitioner, Convenience and more
    • The Company has multiple certifications, and executive memberships that take anywhere from 18-24 months to replicate in addition to a significant capital investment
    • HempFusion is a board member of the US Hemp Roundtable, a coalition of leading companies committed to advancing safe hemp and CBD products
    • Ola Lessard, HempFusion’s CMO, is the President of the US Hemp Roundtable
  • Multiple Revenue Drivers

    • FDA Drug Listed OTC Topicals allow access to the largest channel by dollar value; Food/Drug/Mass (Big Box)
    • Convenience Channel, providing access to significant new sales & distribution opportunities
    • Products are currently sold in 4,000+ retail locations across 50 states including Sprouts, Vitamin Shoppe, and Fresh Thyme Market
    • Revenue opportunities from 5 robust channels; Natural, Ecommerce, Big Box, Convenience and Doctor Practitioner
  • Proprietary CBD Product Portfolio

    • The Company’s diverse product portfolio includes 46 products on the market from tinctures to proprietary FDA Drug Listed Over-The-Counter (“OTC”) Topicals to Doctor/Practitioner Lines and Probulin’s scientifically validated delivery systems
    • HempFusion Wellness Inc.’s family of brands includes: HempFusion, Probulin Probiotics, Biome Research, and HF Labs

Latest News

  • January 14th, 2021
    HempFusion Expands Global Footprint to Europe Through Ireland
    READ MORE
  • January 12th, 2021
    HempFusion Announces USDA Organic Certification for Its CBD Tinctures
    READ MORE
  • January 6th, 2021
    Hempfusion Wellness Inc. Completes USD$17,000,000 Initial Public Offering and Commences Trading on the Toronto Stock Exchange
    READ MORE
  • October 22nd, 2020
    Hempfusion Wellness Inc. Files Preliminary Prospectus for Initial Public Offering of Common Shares and Units
    READ MORE
  • June 25th, 2020
    HempFusion® Participates and Sponsors Industry Leading Study on CBD and Human Health
    READ MORE
  • June 11th, 2020
    HempFusion® Launches Innovative Over-the-Counter ("OTC") Topical Products Allowing For Targeted Relief
    READ MORE
  • December 10th, 2019
    Response to Recent Communications by the FDA
    READ MORE
  • November 26th, 2019
    HempFusion® Launches Sitewide "Black Friday" Sale!
    READ MORE
  • November 19th, 2019
    HempFusion® Announces North American Airport CBD Marketing Campaign
    READ MORE
  • November 7th, 2019
    HempFusion® Announces Expanded United States Distribution
    READ MORE
  • October 29th, 2019
    HempFusion® Announces Autism Hope Alliance Sponsorship
    READ MORE
  • October 18th, 2019
    HempFusion Launches Innovative Broad Spectrum CBD Twist Products
    READ MORE
  • September 27th, 2019
    Pro Snowboarder and Film Maker Travis Rice Partners with Leading CBD Brand, HempFusion
    READ MORE
  • September 10th, 2019
    HempFusion® Announces Launch of Terpene-Infused Broad Spectrum CBD Topicals
    READ MORE
  • August 14th, 2019
    HempFusion, Inc., a Leading US hemp-based CBD Company, Closes US$36,000,000 Financing
    READ MORE
  • June 10th, 2019
    HempFusion Announces Customer Appreciation Super Sale Event
    READ MORE
  • May 30th, 2019
    HempFusion Announces Strategic Partnership with Financial Group RADD Capital
    READ MORE

FDA Drug Listed Over the Counter Topicals

We’ve created a unique Over-The-Counter (OTC) drug-listed topical line to provide relief for pain and help reduce the symptoms of eczema and acne. This line includes broad-spectrum hemp extract CBD that harnesses true broad-spectrum power plus a greater diversity of naturally-occurring cannabinoids and other compounds. They work together to support the entourage effect and deliver the most benefits.

  • Aging Cream

    CBD Anti Aging Cream

    65 mg - 30mL
    $19.99
    Subscribe monthly & Save 25%
  • Pain Relief Balm

    50 mg - 1.4 oz
    $19.99
    Subscribe monthly & Save 25%
  • Acne Relief

    Acne Relief Cream

    60 mg - 30mL
    $19.99
    Subscribe monthly & Save 25%
  • Eczema Relief Cream

    100 mg - 50mL
    $19.99
    Subscribe monthly & Save 25%
  • Pain Relief Gel

    Pain Relief Gel

    65 mg - 50mL
    $24.99
    Subscribe monthly & Save 25%
  • Sports Pain Relief Balm

    80 mg - 1.4oz
    $24.99
    Subscribe monthly & Save 25%
  • Pain Relief Cream

    60 mg - 50mL
    $19.99
    Subscribe monthly & Save 25%

HempFusion Investor Relations Contact

Spencer MacLean
Tel:416-803-5638
Email: [email protected]

(1) Please click here for reference
(2) Leveraging non-CBD products to achieve approved vendor status
(3) Based on available public company presentations and June 30, 2020 Financials

Sign up to get access to everything HempFusion